About
Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an advisor to a number of pharmaceutical and biotechnology companies. He is a founder of Pernix Therapeutics Holdings, Inc, (PTX: NASDAQ), a specialty pharmaceutical company focused on branded, generic, and OTC products. Mr. Collins was a member of the Pernix Board of Directors from 2007 to 2014 and served as President and CEO from 2008 to 2013. Mr. Collins also serves as a Board Member and as Chairman of the Compensation Committee for TherapeuticsMD, Inc, (TXMD:NYSE MKT), a healthcare company focused on developing and commercializing products targeted exclusively for women.
Position in the VCSift Database
- • 1,305 investors hold the Chief Executive Officer role in VCSift. Cooper C. Collins is one of them.
- • 801 investors are based in Houston, Texas, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Houston, US
Contact Information
Find more investors like Cooper
Search Investors